Geron is down a bit on the day, funds flowing out kept the price down -2.08% since yesterday.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Geron hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. It may find some support around the $1.4 price level in the near term.
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 99 | -0.926364 | -1.75616 | -5.24131 | 7.98838 | 3.72091 | 35.8212 | 37.7778 | 12.377 | 11.9278 | 17.2328 | -15323.7 | -12011.4 | 2.7778 | 30.0505 | 6.72972 | 1.11212 |
| Healthcare | 229 | 0.405852 | 1.42847 | 1.15197 | 13.0811 | 7.67729 | 31.7387 | 42.3712 | 16.5638 | 11.0205 | 11.8165 | -12521.1 | -10826.1 | 4.1485 | 19.7598 | 5.29792 | 0.761266 |